These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11996884)

  • 1. Interaction of mammalian O(6)-alkylguanine-DNA alkyltransferases with O(6)-benzylguanine.
    Loktionova NA; Pegg AE
    Biochem Pharmacol; 2002 Apr; 63(8):1431-42. PubMed ID: 11996884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved residue lysine165 is essential for the ability of O6-alkylguanine-DNA alkyltransferase to react with O6-benzylguanine.
    Xu-Welliver M; Kanugula S; Loktionova NA; Crone TM; Pegg AE
    Biochem J; 2000 Apr; 347(Pt 2):527-34. PubMed ID: 10749683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations at multiple sites including highly conserved amino acids maintain activity, but render O6-alkylguanine-DNA alkyltransferase insensitive to O6-benzylguanine.
    Xu-Welliver M; Pegg AE
    Biochem J; 2000 Apr; 347(Pt 2):519-26. PubMed ID: 10749682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of human O6-alkylguanine-DNA alkyltransferase mutants highly resistant to inactivation by O6-benzylguanine.
    Xu-Welliver M; Kanugula S; Pegg AE
    Cancer Res; 1998 May; 58(9):1936-45. PubMed ID: 9581836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of codon 160 in the sensitivity of human O6-alkylguanine-DNA alkyltransferase to O6-benzylguanine.
    Xu-Welliver M; Leitão J; Kanugula S; Meehan WJ; Pegg AE
    Biochem Pharmacol; 1999 Oct; 58(8):1279-85. PubMed ID: 10487529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the conserved residue tyrosine-158 to histidine renders human O6-alkylguanine-DNA alkyltransferase insensitive to the inhibitor O6-benzylguanine.
    Xu-Welliver M; Leitão J; Kanugula S; Pegg AE
    Cancer Res; 1999 Apr; 59(7):1514-9. PubMed ID: 10197622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.
    Crone TM; Goodtzova K; Edara S; Pegg AE
    Cancer Res; 1994 Dec; 54(23):6221-7. PubMed ID: 7954470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
    Liu L; Schwartz S; Davis BM; Gerson SL
    Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.
    Loktionova NA; Xu-Welliver M; Crone TM; Kanugula S; Pegg AE
    Biochem Pharmacol; 1999 Jul; 58(2):237-44. PubMed ID: 10423163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
    Cai Y; Wu MH; Xu-Welliver M; Pegg AE; Ludeman SM; Dolan ME
    Cancer Res; 2000 Oct; 60(19):5464-9. PubMed ID: 11034089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the Ada O6-alkylguanine-DNA alkyltransferase conferring sensitivity to inactivation by O6-benzylguanine and 2,4-diamino-6-benzyloxy-5-nitrosopyrimidine.
    Crone TM; Kanugula S; Pegg AE
    Carcinogenesis; 1995 Aug; 16(8):1687-92. PubMed ID: 7634390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid change in human O6-alkylguanine-DNA alkyltransferase decreasing sensitivity to inactivation by O6-benzylguanine.
    Crone TM; Pegg AE
    Cancer Res; 1993 Oct; 53(20):4750-3. PubMed ID: 8402653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine.
    Liu L; Spiro TP; Qin X; Majka S; Haaga J; Schupp J; Willson JK; Gerson SL
    Clin Cancer Res; 2001 Aug; 7(8):2318-24. PubMed ID: 11489807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.
    Ewesuedo RB; Wilson LR; Friedman HS; Moschel RC; Dolan ME
    Cancer Chemother Pharmacol; 2001; 47(1):63-9. PubMed ID: 11221964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity of human and mouse alkyltransferase to O6-benzylguanine using a transgenic model.
    Liu L; Lee K; Wasan E; Gerson SL
    Cancer Res; 1996 Apr; 56(8):1880-5. PubMed ID: 8620508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of the O(6)-alkylguanine-DNA alkyltransferase encoded by the ogt(ST) gene from S. typhimurium in protection against alkylating drugs, resistance to O(6)-benzylguanine and sensitisation to dibromoalkane genotoxicity.
    Abril N; Luque-Romero FL; Yamada M; Nohmi T; Pueyo C
    Mutat Res; 2001 Oct; 497(1-2):111-21. PubMed ID: 11525913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of O6-benzylguanine-resistant mutants of human O6-alkylguanine-DNA alkyltransferase with O6-benzylguanine in oligodeoxyribonucleotides.
    Pegg AE; Kanugula S; Edara S; Pauly GT; Moschel RC; Goodtzova K
    J Biol Chem; 1998 May; 273(18):10863-7. PubMed ID: 9556560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation of human O6-alkylguanine-DNA alkyltransferase confers resistance to O6-benzylguanine].
    Wan Y; Wu D; Gao H
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):290-3. PubMed ID: 11778552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of MGMT in the treatment of cancer.
    Gerson SL
    J Clin Oncol; 2002 May; 20(9):2388-99. PubMed ID: 11981013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer.
    Wu MH; Lohrbach KE; Olopade OI; Kokkinakis DM; Friedman HS; Dolan ME
    Clin Cancer Res; 1999 Jan; 5(1):209-13. PubMed ID: 9918221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.